Does METOPROLOL Cause Basal cell carcinoma? 96 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Basal cell carcinoma have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.2% of all adverse event reports for METOPROLOL.
96
Reports of Basal cell carcinoma with METOPROLOL
0.2%
of all METOPROLOL reports
1
Deaths
23
Hospitalizations
How Dangerous Is Basal cell carcinoma From METOPROLOL?
Of the 96 reports, 1 (1.0%) resulted in death, 23 (24.0%) required hospitalization, and 2 (2.1%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which METOPROLOL Alternatives Have Lower Basal cell carcinoma Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE